MINNEAPOLIS, June 03, 2024 Celcuity Inc. , a clinical-stage biotechnology company pursuing development of targeted therapies for oncology, today announced its participation in the Jefferies.
Celcuity (NASDAQ:CELC) Stock Price Up 8.1% modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.
Celcuity Announces Pricing of Underwritten Common Stock Offering marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.
Celcuity Inc. Announces Plan to Initiate a Phase 3 Clinical Trial for Gedatolisib as First-Line ... eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright reissued their buy rating on shares of Celcuity (NASDAQ:CELC – Free Report) in a report released on Thursday morning, Benzinga reports. They currently have a $27.00 price objective on the stock. HC Wainwright also issued estimates for Celcuity’s FY2028 earnings at $4.08 EPS. A number of other analysts also recently weighed in on […]